Navigation Links
Amgen's First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
Date:4/23/2009

nts with previously untreated metastatic colorectal cancer ('203 study). The review of the blinded data available to date indicated that there had not been sufficient progression events to meet the minimum number as outlined in the statistical analysis plan. Therefore, the company elected to accrue additional data and now anticipates the '203 study results in the third quarter. The company also anticipates results in the third quarter from a Phase 3 study comparing the efficacy of panitumumab in combination with Irinotecan/ 5-Fluorouracil/Leucovorin to the efficacy of Irinotecan/ 5-Fluorouracil/Leucovorin alone in patients with previously treated metastatic colorectal cancer ('181 study). In addition, a Phase 3 study to compare efficacy of panitumumab in combination with chemotherapy versus chemotherapy alone as first line therapy for metastatic and/or recurrent squamous cell carcinoma of the head and neck has completed enrollment.

Non-GAAP Financial Measures

Management has presented its operating results in accordance with GAAP and on an "adjusted" (or non-GAAP basis) for the three months ended March 31, 2009 and 2008. In addition, management has presented its outstanding debt in accordance with GAAP and on an "adjusted" (or non-GAAP basis) at March 31, 2009. The Company believes that the presentation of non-GAAP financial measures provides useful supplementary information to and facilitates additional analysis by investors. The Company uses these non-GAAP financial measures in connection with its own budgeting and financial planning. These non-GAAP financial measures are in addition to, not a substitute for, or superior to, measures of financial performance prepared in conformity with GAAP.

Forward-Looking Statements

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... HealthDay Reporter THURSDAY, July 31, ... West Africa has a well-earned reputation as one of the ... and intense medical care can greatly improve a person,s chances ... which wreaks life-threatening havoc within the body by attacking multiple ... fall back on the basics of "good meticulous intensive care," ...
(Date:8/1/2014)... New research shows that people who grew up in ... 16-percent greater risk of experiencing poor health quality than ... to prison. The finding, which accounted for other forms ... of imprisonment may be independently imparting enduring physical and ... were children when this happened, and it was a ...
(Date:8/1/2014)... August 01, 2014 Did you know that ... Sarcoma Awareness Month is to raise awareness across the country ... options for, sarcoma. According to the American Cancer Society, nearly ... 2014, while 12,000 new soft tissue sarcomas will be diagnosed. ... sarcoma tumors as they are other kinds of cancer,” said ...
(Date:8/1/2014)... Seattle, Wa (PRWEB) August 01, 2014 According ... Vkool.com, this is a comprehensive diet guide for women who ... discover a list of protein rich foods and ... keeping lean muscle mass. , Vkool writes in its review ... to readers the truth about fat burning hormones and weight ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Blindness is ... argued that the scientists of today, despite well-meaning efforts, still ... providing a definite treatment for reversing blindness that does not ... sense, this is where alternative medicine takes the “slack” from ... on expensive treatments or harmful surgeries. , Alternative health ...
Breaking Medicine News(10 mins):Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 2Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 3Health News:Jailed family member increases risks for kids' adult health 2Health News:Jailed family member increases risks for kids' adult health 3Health News:July Was Sarcoma Awareness Month! 2Health News:July Was Sarcoma Awareness Month! 3Health News:July Was Sarcoma Awareness Month! 4Health News:The Metabolic Switch Diet PDF Review Exposes Sally Asher's Diet Guide For Boosting Metabolism – Vkool.com 2Health News:The Metabolic Switch Diet PDF Review Exposes Sally Asher's Diet Guide For Boosting Metabolism – Vkool.com 3Health News:The Miracle Cure Review | The Unbeatable Secret to Reversing Any Vision Problem – Vinamy.com 2
... breast conservation surgery is the most common type of ... surgery is that only part of the breast is ... appearance of the breast, which may be disfigured, dented ... Surgery, the official medical journal of the American Society ...
... Business Alliance will help to raise funds and ... Logistics, an industry leader,focused on single-source supply chain ... K2 Logistics, headquartered in Eagan, announced,today its K2 ... (PAM) Team. Also joining in the fight against ...
... 90th Annual MeetingENDO 08will be held at the Moscone ... , Reporters can register here: http://www.endo-society.org/media/ENDO-08/ ... the world are expected to assemble for this premier ... , It is the opportunity for journalists to learn ...
... from 11 to 17 years of age smoke. This ... and Examination Survey for Children and Adolescents (KiGGS), performed ... sociologist Thomas Lampert in the current edition of Deutsches ... The analysis of tobacco consumption by children and adolescents ...
... International,Inc. (Nasdaq: CHDX ) a leading independent ... the People,s Republic of China, today,announced that Roberta ... following investment conferences in New York City:, ... being held,from May 19-20, 2008 at The Waldorf ...
... Offerings Thus ... Far, ... health care system or state legislation,mandating coverage. Instead, they prefer relying on ... and the National Business Group on Health., More than three-quarters (84 ...
Cached Medicine News:Health News:Breast reconstruction advances fix distortions left by lumpectomy 2Health News:K2 Logistics & Strategic Warehousing Join The Parkinson Association of Minnesota (PAM) Team! 2Health News:K2 Logistics & Strategic Warehousing Join The Parkinson Association of Minnesota (PAM) Team! 3Health News:ENDO 08: Latest news on hormones, steroids, obesity, diabetes and more 2Health News:Chindex International, Inc. to Present at China Investment Conferences in New York City - May 20, 21, 22; Conferences Presented By Brean Murray, Carret & Co., Oppenhiemer & Co. and Citigroup 2Health News:Chindex International, Inc. to Present at China Investment Conferences in New York City - May 20, 21, 22; Conferences Presented By Brean Murray, Carret & Co., Oppenhiemer & Co. and Citigroup 3Health News:Most Companies Oppose Single-Payer Health Care System, State Coverage Mandates 2
(Date:8/1/2014)... 2014 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ... to report its second quarter 2014 financial results on ... Dr. J. Joseph Kim and CFO ... a corporate update, and participate in a live Q&A ... for VGX-3100, Inovio,s immune therapy targeting pre-cancers and cancers ...
(Date:8/1/2014)... Arena Pharmaceuticals, Inc. (NASDAQ: ... reported financial results for the second quarter ended ... continued to see encouraging advancements in the US ... in estimated total prescriptions and estimated total per ... Lief, Arena,s President and Chief Executive Officer. "Other ...
(Date:7/31/2014)... August 1, 2014 ... gaben heute bekannt, vor kurzem für OneDose ... Schmerzbehandlung nach chirurgischen Eingriffen eine kommerzielle Zusammenarbeit ... Europäischen Union und weiterer europäischer Länder abdeckt. ... mit Ropivacain gefüllte OneDose ReadyfusOR später in ...
Breaking Medicine Technology:Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 2Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 3
... LAKE SUCCESS, N.Y., Sept. 7, 2011 As NFL coaches ... strength and conditioning programs, one team,s preparation will be gaining ... during the 2011 NFL season. Today, Polar USA and the ... has been designated the "Official Heart Rate Training System" of ...
... 7, 2011 Cyberonics, Inc. (NASDAQ: CYBX ), ... participate in the 2011 UBS Global Life Sciences Conference on ... Moore, Cyberonics, President and Chief Executive Officer, will speak to ... live audio webcast of the presentation can be accessed by ...
Cached Medicine Technology:Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons 2Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons 3
Adjustable tilt angle 0 to 20 Adjustable speed of 3-25 RPM Load capacity: 2.7 kg (6 lbs.) Ambient temperature range 4C to 65C Low voltage power is supplied by wall mount transformer...
Conversion Kits For Modular Incubator Chamber...
... The AutoIncubator 96 can incubate and shake ... prepare 96 samples at a time. This ... and enzyme reactions, such as Proteinase K digestion. ... extraction process by preparing your samples with our ...
Inquire...
Medicine Products: